I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 36% ± 12% | |
| glutamatergic neuron | 4 studies | 43% ± 16% | |
| astrocyte | 3 studies | 28% ± 7% | |
| oligodendrocyte | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 36% ± 12% | |
| glutamatergic neuron | 4 studies | 43% ± 16% | |
| astrocyte | 3 studies | 28% ± 7% | |
| oligodendrocyte | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 33% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 601.03 | 1444 / 1445 | 100% | 10.69 | 183 / 183 |
| stomach | 100% | 527.91 | 359 / 359 | 100% | 9.76 | 285 / 286 |
| breast | 100% | 734.50 | 459 / 459 | 99% | 9.95 | 1111 / 1118 |
| lung | 99% | 630.14 | 575 / 578 | 100% | 8.69 | 1153 / 1155 |
| ovary | 100% | 702.03 | 180 / 180 | 99% | 7.03 | 427 / 430 |
| bladder | 100% | 728.19 | 21 / 21 | 99% | 9.65 | 500 / 504 |
| intestine | 100% | 633.39 | 966 / 966 | 99% | 9.88 | 521 / 527 |
| prostate | 100% | 727.55 | 245 / 245 | 99% | 11.52 | 496 / 502 |
| brain | 99% | 430.23 | 2610 / 2642 | 100% | 7.02 | 702 / 705 |
| pancreas | 100% | 752.11 | 328 / 328 | 98% | 6.69 | 175 / 178 |
| thymus | 100% | 948.03 | 653 / 653 | 97% | 7.61 | 589 / 605 |
| uterus | 100% | 865.31 | 170 / 170 | 96% | 7.76 | 442 / 459 |
| kidney | 100% | 461.11 | 89 / 89 | 92% | 5.56 | 826 / 901 |
| skin | 100% | 1168.26 | 1809 / 1809 | 88% | 5.74 | 417 / 472 |
| adrenal gland | 100% | 458.17 | 257 / 258 | 87% | 4.01 | 199 / 230 |
| liver | 100% | 541.73 | 226 / 226 | 82% | 4.58 | 331 / 406 |
| adipose | 100% | 636.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 661.49 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.06 | 1 / 1 |
| blood vessel | 100% | 667.20 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 353.48 | 794 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 6.71 | 44 / 45 |
| heart | 92% | 312.91 | 793 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 86% | 763.27 | 798 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 4.11 | 23 / 29 |
| eye | 0% | 0 | 0 / 0 | 44% | 1.57 | 35 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0016020 | Cellular component | membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | NFXL1 |
| Protein name | NF-X1-type zinc finger protein NFXL1 (Ovarian zinc finger protein) (hOZFP) Alternative protein NFXL1 |
| Synonyms | OZFP |
| Description | |
| Accessions | ENST00000464756.6 [Q6ZNB6-2] L8EBF0 ENST00000329043.7 [Q6ZNB6-1] ENST00000381538.7 [Q6ZNB6-1] Q6ZNB6 ENST00000507489.2 [Q6ZNB6-1] |
